While FLT3-ITD is generally associated with resistance and disease progression in AML [28], FLT3-ITDs did not seem to confer clonal advantage in UBTF-TD AML when not associated with WT1 mutation. The gene discussed is FLT3; the disease is acute myeloid leukemia.